Patents Assigned to Biostar Medical Products, Inc.
  • Patent number: 4757024
    Abstract: The use of immunologically non-specific peptide linked amino acids containing compounds that are capable of immobilizing circulating immune complexes for the purpose of detection or removal from serum or blood, such compounds including oligopeptides, modified oligopeptides, polypeptides, modified polypeptides, proteins, modified proteins, and in particular glycosylated polypeptides and proteins.
    Type: Grant
    Filed: August 8, 1985
    Date of Patent: July 12, 1988
    Assignee: Biostar Medical Products, Inc.
    Inventor: Michael D. Roper
  • Patent number: 4753893
    Abstract: The use of the ability of immunologically non-specific peptide linked amino acid containing compounds to combine with anti-antibodies or rheumatoid factor to provide for a method of detecting rheumatoid factor and for a method of immobilizing circulating immune complexes from fluids for the purpose of detection or removal thereof from body fluids, such as serum or blood.
    Type: Grant
    Filed: November 6, 1986
    Date of Patent: June 28, 1988
    Assignee: Biostar Medical Products, Inc.
    Inventor: Michael D. Roper
  • Patent number: 4681782
    Abstract: An immunoassay of a specimen of a serum or the like to determine the composition of immune complexes, includes producing on a plastic base a layer of a non-proteinaceous, non-ionic polymer which will adhere to the plastic base and has the capability of adsorbing immune complexes of the specimen, placing a specimen on the layer and treating the layer to produce an indication of the composition of the immune complexes. The polymer may be polyethylene glycol, dextran, polyvinyl chloride, a polymeric polyol or an adduct of polyethylene glycol or mixtures thereof. Washing with conventional solutions, addition of monoclonal and/or polyclonal antibodies coupled with an enzyme and addition of a substrate reactive therewith to determine the antigen component, are similar to the ELISA test, with color measurement as by spectrophotometer. Or, the addition of anti IgG-I.sup.125 and measurement by a scintillation counter may be used. Addition of IgG, IgA, IgE, IgG.sub.
    Type: Grant
    Filed: October 3, 1983
    Date of Patent: July 21, 1987
    Assignee: Biostar Medical Products, Inc.
    Inventor: Adil N. Ozkan
  • Patent number: 4450231
    Abstract: An immunoassay of a specimen of a serum or the like to determine immune complexes, includes producing on a plastic base a layer of a non-proteinaceous, non-ionic polymer which will adhere to the plastic base and has the capability of absorbing immune complexes of the specimen, placing a specimen on the layer and treating the layer to produce an indication of the amount of immune complexes. The polymer may be polyethylene glycol, dextran, polyvinyl chloride, a polymeric polyol or an adduct of polyethylene glycol. Washing with conventional solutions, addition of an antihuman IgG coupled with an enzyme and addition of a substrate reactive therewith, are similar to the ELISA test, with color measurement as by spectrophotometer. Or, the addition of anti IgG-I.sup.125 and measurement by a scintillation counter may be used. The ethylene glycol may range in molecular weight from 2,000 to 20,000, although 6,000 to 8,000 is preferred.
    Type: Grant
    Filed: March 31, 1982
    Date of Patent: May 22, 1984
    Assignee: Biostar Medical Products, Inc.
    Inventor: Adil N. Ozkan